We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Simple Calcium Test Negates Cardiac Event Likelihood

By HospiMedica International staff writers
Posted on 25 Feb 2010
Coronary artery calcium scoring (CACS), a simple and inexpensive noninvasive test can determine whether it is safe to send home a patient who arrives at the emergency room (ER) with chest pain. More...


Researchers at the Methodist DeBakey Heart & Vascular Center (Houston, TX, USA) conducted a prospective observational cohort study at The Methodist Hospital (Houston, TX, USA) of 1,031 stable patients presenting to the ER with chest pain of uncertain cardiac etiology. Patients with a normal initial troponin level, a nonischemic electrocardiogram (ECG), and no prior history of coronary artery disease (CAD) had stress myocardial perfusion imaging (SPECT) and CACS performed within 24 hours of ER admission. The CACS results were assessed in relation to SPECT findings and cardiac events, which were defined as an acute coronary syndrome during the index hospitalization or in follow-up.

The results showed that 61% of the patients evaluated for chest pain of uncertain cardiac etiology had a CACS of zero, which predicted both a normal SPECT and an excellent short-term outcome. The frequency of an abnormal SPECT ranged from 0.8% (when CACS was 0) to 17% (CACS of over 400). Cardiac events occurred in 32 patients (3.1%) during the index hospitalization or following hospital discharge. Only two events occurred in 625 patients with a CACS of zero, and both of these patients developed elevated troponin levels during their index visit, but had normal serial ECG and SPECT results and no cardiac events at six-month follow-up. The researchers concluded that properly selected patients who have a CACS of zero could be discharged home without further cardiac testing. The study was published early online on February 5, 2010, in the Annals of Emergency Medicine.

"It is imperative to accurately diagnose patients who come to the emergency department with chest pain,” said lead author cardiologist John Mahmarian, M.D. "Unfortunately, diagnosing chest pain is often expensive and time-consuming. This new data could save millions of health care dollars and countless hours spent waiting on unnecessary tests.”

CACS is performed with a computed tomography (CT) scan to create a detailed image of the heart, showing calcium build up in the coronary arteries; the images can be read almost immediately after the scan. A CACS of zero correlates with an excellent short-term outcome and predicts a normal SPECT, which is a more advanced imaging test that is usually done following a CACS test.

Related Links:

Methodist DeBakey Heart & Vascular Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.